NurExone’s ExoPTEN Being Studied as Glaucoma Treatment for US$3.4 Billion Market
28. Juni 2024 16:04 ET
|
NurExone Biologic Inc
Prestigious Eye Institute Exploring New Indication for NurExone’s ExoPTEN